These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26899388)

  • 1. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
    Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
    Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
    van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
    Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
    Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
    Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples.
    Punt S; Baatenburg de Jong RJ; Jordanova ES
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28784947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
    Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
    Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
    Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature.
    Saber CN; Grønhøj Larsen C; Dalianis T; von Buchwald C
    Oral Oncol; 2016 Jul; 58():8-13. PubMed ID: 27311396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and prognostic impact of proinflammatory cytokines and their associations with carcinogens in oropharyngeal squamous cell carcinoma.
    Lin CM; Lin LW; Chen YW; Ye YL
    Cancer Immunol Immunother; 2020 Apr; 69(4):549-558. PubMed ID: 31970439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma.
    Punt S; van Vliet ME; Spaans VM; de Kroon CD; Fleuren GJ; Gorter A; Jordanova ES
    Cancer Immunol Immunother; 2015 Jun; 64(6):745-53. PubMed ID: 25795131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
    Anayannis NV; Schlecht NF; Belbin TJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Ruangritchankul K; Sandison A; Warburton F; Guerrero-Urbano T; Reis Ferreira M; Lei M; Thavaraj S
    Histopathology; 2019 Jul; 75(1):146-150. PubMed ID: 31144335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.
    Santegoets SJ; Duurland CL; Jordanova ES; van Ham JJ; Ehsan I; van Egmond SL; Welters MJP; van der Burg SH
    J Immunother Cancer; 2019 Jan; 7(1):14. PubMed ID: 30658697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13
    Yan S; Zhang X; Lin Q; Du M; Li Y; He S; Chen J; Li X; Bei J; Chen S; Song M
    Cancer Immunol Immunother; 2024 Aug; 73(10):206. PubMed ID: 39105803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral HPV16-Specific T Cells Constitute a Type I-Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer.
    Welters MJP; Ma W; Santegoets SJAM; Goedemans R; Ehsan I; Jordanova ES; van Ham VJ; van Unen V; Koning F; van Egmond SI; Charoentong P; Trajanoski Z; van der Velden LA; van der Burg SH
    Clin Cancer Res; 2018 Feb; 24(3):634-647. PubMed ID: 29018052
    [No Abstract]   [Full Text] [Related]  

  • 20. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
    Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
    J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.